GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	5.17B +71.4%
Revenue (ttm)	3.74B +33.3%
Net Income	98.36M -17.7%
EPS	1.17 -18.3%
Shares Out	83.51M
PE Ratio	52.82
Forward PE	n/a
Dividend	1.00 (1.62%)
Ex-Dividend Date	Jan 12, 2026

Volume	4,250
Average Volume	23,123
Open	61.89
Previous Close	61.89
Day's Range	61.50 - 62.18
52-Week Range	32.66 - 81.50
Beta	0.81
RSI	48.98
Earnings Date	Mar 18, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.